Pulmonary Vascular Disease in Valvular Heart Disease: How Valve Procedures Affect Blood Flow
Official title: Clinical Implications of Pulmonary Vascular Disease in Valvular Heart Disease
Run by Mayo Clinic · NCT07483203 · Data updated 2026-11-12
This study tests how blood flow in the lungs changes in adults with left-sided valve disease who are having valve surgery and looks to see if patterns can predict reversibility of tricuspid regurgitation and right heart dysfunction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | April 28, 2026 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07483203 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older who are scheduled for aortic or mitral valve procedures and can undergo echocardiography.
✕Probably not a fit
Patients who are not undergoing valve procedures or who have conditions that prevent complete follow-up may not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will characterize pulmonary hemodynamics, especially pulmonary vascular resistance subtypes, in adults with left-sided valvular heart disease undergoing aortic or mitral valve procedures. Echocardiography will be used to collect data on heart pressures and function before and after intervention. The goal is to identify patterns that predict whether tricuspid regurgitation and right ventricular dysfunction may improve following valve surgery. Conducted at Mayo Clinic in Rochester, the study will help clarify how valve interventions impact pulmonary circulation and right heart performance. Participation is limited to adults scheduled for valve procedures with standard exclusions to ensure safe and complete data collection.
Why it matters
Potential benefit: If successful, the findings could improve prediction of which patients will experience improvement in right heart function after valve surgery.
How similar studies have gone: Similar centers have used pulmonary hemodynamics to understand valve disease, but this exact focus on reversibility of RV dysfunction post-surgery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years old; AND * Scheduled for valve procedures Exclusion Criteria: * Congenital heart disease (except for bicuspid aortic valve), OR * Carcinoid heart disease, OR * Valvular mass, OR * Endocarditis, OR * Any other condition that, in the opinion of the investigator, would impair their ability to complete the study
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Barry Borlaug, MD — Mayo Clinic
- Study coordinator: Annabelle Fuenffinger
- Email: fuenffinger.annabelle@mayo.edu
- Phone: 507-422-3801
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of ambient air vs nasal liquid oxygen on exercise performance in pulmonary vascular disease
This study tests whether using nasal liquid oxygen during a 6-minute walk test changes how far patients with PAH or CTEPH can walk compared to breathing room air.
-
Liquid oxygen vs ambient air during a 6-minute walk in people with pulmonary vascular disease
This study tests whether walking with liquid oxygen at about 4 L/min helps or hinders distance walked compared with walking on room air in adults with PAH or CTEPH living in Switzerland.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Heart sound signals to detect valve and artery disease early
This observational study tests whether a new digital stethoscope-like device can pick up heart sound patterns to detect valvular or coronary artery disease earlier in people who are already getting heart imaging.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
MMVD: A Multicenter Registry to Understand Multiple and Mixed Valvular Heart Disease
This study tests how common MMVD is, what imaging and management practices are used, and what factors influence outcomes in adults with two or more valve issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.